Synthesis and Leishmanicidal Activity of 1-[5-(5-Nitrofuran-2-yl)-1, 3, 4-Thiadiazole-2-yl]-4-BenzoylePiperazines
暂无分享,去创建一个
[1] Y. Hamzavi,et al. Trend of Cutaneous Leishmaniasis in Kermanshah Province, West of Iran from 1990 To 2012 , 2015, Iranian journal of parasitology.
[2] M. Mohebali. Visceral leishmaniasis in Iran: Review of the Epidemiological and Clinical Features , 2013, Iranian journal of parasitology.
[3] S. Kaur,et al. Vaccine candidates for leishmaniasis: a review. , 2011, International immunopharmacology.
[4] A. Shafiee,et al. Synthesis and antileishmanial activity of novel 5-(5-nitrofuran-2-y1)-1,3,4-thiadiazoles with piperazinyl-linked benzamidine substituents. , 2011, European journal of medicinal chemistry.
[5] R. Uddin,et al. Synthesis, antioxidant activities and urease inhibition of some new 1,2,4-triazole and 1,3,4-thiadiazole derivatives. , 2010, European journal of medicinal chemistry.
[6] A. Kadi,et al. Synthesis, antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-1,3,4-thiadiazole derivatives. , 2010, European journal of medicinal chemistry.
[7] H. Abdel‐Aziz,et al. Synthesis and antimicrobial evaluation of some 1,3-thiazole, 1,3,4-thiadiazole, 1,2,4-triazole, and 1,2,4-triazolo[3,4-b][1,3,4]-thiadiazine derivatives including a 5-(benzofuran-2-yl)-1-phenylpyrazole moiety , 2009 .
[8] A. Kariminia,et al. Selective leishmanicidal effect of 1,3,4-thiadiazole derivatives and possible mechanism of action against Leishmania species. , 2009, Experimental parasitology.
[9] A. Shafiee,et al. Synthesis and in vitro anti-leishmanial activity of 1-[5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-yl]- and 1-[5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl]-4-aroylpiperazines. , 2008, Bioorganic & medicinal chemistry.
[10] J. Matysiak,et al. 2-(2,4-dihydroxyphenyl)-1,3,4-thiadiazole analogues: Antifungal activity in vitro against Candida species , 2007, Russian Journal of Bioorganic Chemistry.
[11] L. Kedzierski,et al. Leishmania vaccines: progress and problems , 2006, Parasitology.
[12] M. Ouellette,et al. Unresponsiveness to Glucantime Treatment in Iranian Cutaneous Leishmaniasis due to Drug-Resistant Leishmania tropica Parasites , 2006, PLoS medicine.
[13] M. Mirzaei,et al. Antituberculosis agents. V. Synthesis, evaluation of in vitro antituberculosis activity and cytotoxicity of some 2-(5-nitro-2-furyl)-1,3,4-thiadiazole derivatives. , 2002, Farmaco.
[14] D. Simoni,et al. 3,6-Disubstituted 1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles: synthesis, antimicrobial and antiviral activity. II. , 1996, Farmaco.
[15] H. Ishikawa,et al. Synthesis and anti-pseudomonal activity of new 2-isocephems with a dihydroxypyridone moiety at C-7 , 1994 .
[16] P. Desjeux,et al. Estimation of population at risk of infection and number of cases of Leishmaniasis. , 1992, Parasitology today.
[17] A. Fuertes,et al. Coordination behavior of acetazolamide (5-acetamido-1,3,4-thiadiazole-2-sulfonamide): synthesis, crystal structure, and properties of bis(acetazolamidato)tetraamminenickel(II) , 1989 .